作者:
Flaherty,L. [1]
;
Hamid,O. [2]
;
Linette,G. [3]
;
Schuchter,L. [4]
;
Hallmeyer,S. [5]
;
Gonzalez,R. [6]
;
Cowey,C.L. [7]
;
Pavlick,A. [8]
;
Kudrik,F. [9]
;
Curti,B. [10]
;
Lawson,D. [11]
;
Chapman,P.B. [12]
;
Margolin,K. [13]
;
Ribas,A. [14]
;
McDermott,D. [15]
;
Flaherty,K. [16]
;
Cranmer,L. [17]
;
Hodi,F.S. [18]
;
Day,B.-M. [19]
;
Linke,R. [20]
;
Hainsworth,J. [21]
作者单位:
Memorial Sloan Kettering Cancer Center, New York, NY, United States
[1]
Massachusetts General Hospital, Boston, MA, United States
[2]
Providence Portland Medical Center, Portland, OR, United States
[3]
Seattle Cancer Care Alliance, Seattle, WA, United States
[4]
Genentech, San Francisco, CA, United States, SFJ Pharma Group, Pleasanton, CA, United States
[5]
Genentech, San Francisco, CA, United States
[6]
Winship Cancer Institute, Emory University, Atlanta, GA, United States
[7]
Beth Israel Deaconess Medical Center, United States
[8]
Angeles Clinic and Research Institute, Los Angeles, CA, United States
[9]
University of Colorado Cancer Center, Aurora, CO, United States
[10]
South Carolina Oncology Associa., Columbia, SC, United States
[11]
UCLA School of Medicine, Los Angeles, CA, United States
[12]
Sarah Cannon Research Institute, Nashville, TN, United States
[13]
Division of Hematology and Oncology, Karmanos Cancer Institute, 4100 John R-4HWCRC, Detroit, MI
[14]
Oncology Specialists S.C., Park Ridge, IL, United States
[15]
NYU Medical Center, New York, NY, United States
[16]
Washington University, St Louis, MO, United States
[17]
Baylor Sammons Cancer Center, Texas Oncology, PA, Dallas, TX, United States
[18]
University of Arizona Cancer Center, Tucson, AZ, United States
[19]
Dana Farber Cancer Institute, Boston, MA, United States
[20]
University of Pennsylvania, Philadelphia, PA, United States
[21]
发布时间
2014-05-07